Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Savara Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Savara Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Savara Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Savara Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Savara Inc, Medical Devices Deals, 2012 to YTD 2018 10
Savara Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Savara Inc, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Savara Acquires Certain Assets and Rights from Cardeas Pharma 13
Venture Financing 14
Savara Pharma Raises USD20 Million in Series C Financing Round 14
Savara Pharmaceuticals Secures USD18.54 Million in Venture Funding 15
Savara Pharma Raises Additional USD5.5 Million in Financing Round 16
Savara Pharma Raises USD4.5 Million in Financing Round 17
Savara Pharma Raises US$14 Million In Series B Financing 18
Partnerships 19
Aires Pharma Enters into Agreement with University of Pittsburgh 19
Serendex Pharma Enters into Agreement with CMC Biologics For Factor VII 20
Merger 21
Mast Therapeutics Merges with Savara 21
Licensing Agreements 23
NobelPharma Enters into Licensing Agreement with Savara 23
NobelPharma Enters into Licensing Agreement with Serendex Pharma 24
Equity Offering 25
Savara Prices Public Offering of Shares for USD48.9 Million 25
Savara Prices Public Offering of Shares for USD47.3 Million 26
Savara Raises USD42.9 Million in Public Offering of Shares 28
Savara to Raise up to USD18 Million in Public Offering of Shares 29
Savara Raises USD8 Million in Public Offering of Shares and Warrants 30
Serendex Pharma Raises USD12.7 Million Rights Offering of Shares 31
Savara Raises USD21 Million in Public Offering of Shares and Warrants 33
Savara Raises USD0.9 Million in Public Offering of Shares up on Exercise of Warrants 34
Serendex Pharma Completes IPO for USD11 Million 35
Savara Raises USD30 Million in Public Offering of Shares 37
Acquisition 38
Savara Pharma Acquires Serendex Pharma 38
Mast Therapeutics Completes Acquisition Of Aires Pharma 39
Savara Inc – Key Competitors 40
Savara Inc – Key Employees 41
Savara Inc – Locations And Subsidiaries 42
Head Office 42
Other Locations & Subsidiaries 42
Recent Developments 43
Financial Announcements 43
May 09, 2018: Savara Reports First Quarter 2018 Financial Results and Provides Business Update 43
Mar 14, 2018: Savara Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update 45
Nov 08, 2017: Savara Reports Third Quarter 2017 Financial Results and Provides Business Update 47
Aug 09, 2017: Savara Reports Second Quarter 2017 Financial Results and Provides Business Update 48
Product News 49
03/06/2017: Mast Therapeutics Announces Clinical Study Of AIR001 For The Treatment Of Chronic Infection In Cystic Fibrosis Patients 49
Clinical Trials 50
May 10, 2017: Savara Announces Expedited U.S. Molgradex Development Strategy 50
Appendix 51
Methodology 51
About GlobalData 51
Contact Us 51
Disclaimer 51
Savara Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Savara Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Savara Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Savara Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Savara Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Savara Inc, Medical Devices Deals, 2012 to YTD 2018 10
Savara Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Savara Acquires Certain Assets and Rights from Cardeas Pharma 13
Savara Pharma Raises USD20 Million in Series C Financing Round 14
Savara Pharmaceuticals Secures USD18.54 Million in Venture Funding 15
Savara Pharma Raises Additional USD5.5 Million in Financing Round 16
Savara Pharma Raises USD4.5 Million in Financing Round 17
Savara Pharma Raises US$14 Million In Series B Financing 18
Aires Pharma Enters into Agreement with University of Pittsburgh 19
Serendex Pharma Enters into Agreement with CMC Biologics For Factor VII 20
Mast Therapeutics Merges with Savara 21
NobelPharma Enters into Licensing Agreement with Savara 23
NobelPharma Enters into Licensing Agreement with Serendex Pharma 24
Savara Prices Public Offering of Shares for USD48.9 Million 25
Savara Prices Public Offering of Shares for USD47.3 Million 26
Savara Raises USD42.9 Million in Public Offering of Shares 28
Savara to Raise up to USD18 Million in Public Offering of Shares 29
Savara Raises USD8 Million in Public Offering of Shares and Warrants 30
Serendex Pharma Raises USD12.7 Million Rights Offering of Shares 31
Savara Raises USD21 Million in Public Offering of Shares and Warrants 33
Savara Raises USD0.9 Million in Public Offering of Shares up on Exercise of Warrants 34
Serendex Pharma Completes IPO for USD11 Million 35
Savara Raises USD30 Million in Public Offering of Shares 37
Savara Pharma Acquires Serendex Pharma 38
Mast Therapeutics Completes Acquisition Of Aires Pharma 39
Savara Inc, Key Competitors 40
Savara Inc, Key Employees 41
Savara Inc, Subsidiaries 42
List of Figures
Savara Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Savara Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Savara Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Savara Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Savara Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Savara Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Savara Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Savara Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Savara Inc, Medical Devices Deals, 2012 to YTD 2018 10